MDRNA, Inc.
MDRNA Receives Additional Funding from National Institutes of Health
Published in TB and Outbreaks Week, September 16th, 2008
MDRNA, Inc. (Nasdaq: MRNA) announced that the National Institutes of Health (NIH) has awarded the Company over $350,000 for further development of the Company's siRNA therapeutics program to prevent and treat influenza. These funds are part of a five-year grant totaling $1.9 million that the NIH awarded the Company in September 2006 to study the underlying scientific principles that enable RNAi to inhibit influenza.
"MDRNA has made great progress in understanding siRNA activity against drug-resistant viruses and how the influenza virus becomes resistant to an RNAi-based therapeutic," said Michael V. Templin, Ph.D., Vice President for Toxicology and Pharmacology. "The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Universite Laval
Intellectual work induces excessive calorie intake - Burness Communications
New Study: Targeted Marketing Promotes Unhealthy Eating Among African Americans - Addiction Medicine
Scientists at Boston University detail research in addiction medicine - Allergies
Research from National Institute of Allergy and Infectious Diseases yields new data on allergies - Anti-Infectives
Researchers from University of Kiel report on findings in anti-infectives - Bacterial Meningitis
New bacterial meningitis study findings have been published by J.J. Vandriel and colleagues - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
